CJ Bioscience, Inc. (KOSDAQ:311690)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Microbiological Analysis	2.98B
Microbiological Analysis Growth	-29.33%
DB Provided	331.54M
DB Provided Growth	32.74%
Intestinal Microbiota Monitoring, Etc.	155.45M
Intestinal Microbiota Monitoring, Etc. Growth	-27.70%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
South Korea	3.00B
South Korea Growth	-27.69%
International	464.75M
International Growth	-12.18%